AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
63 hedge funds and large institutions have $57.7M invested in AVEO Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
Holders
63
Holding in Top 10
–
Calls
$7.03M
Puts
$5.76M
Top Buyers
| 1 | +$4.07M | |
| 2 | +$491K | |
| 3 | +$399K | |
| 4 |
PP
PDT Partners
New York
|
+$367K |
| 5 |
State Street
Boston,
Massachusetts
|
+$353K |
Top Sellers
| 1 | -$2.14M | |
| 2 | -$2.08M | |
| 3 | -$1.84M | |
| 4 |
6CM
683 Capital Management
New York
|
-$1.73M |
| 5 |
Morgan Stanley
New York
|
-$1.35M |